Paul Hagan
Overview
Explore the profile of Paul Hagan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
316
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Daneshvar H, Molaei M, Malekpour Afshar R, Kamiabi H, Burchmore R, Hagan P, et al.
Vet Immunol Immunopathol
. 2009 Jan;
129(1-2):28-35.
PMID: 19147233
The clinicopathological changes following infection with an attenuated line of Leishmania infantum (L. infantum H-line) were evaluated in mixed breed dogs. Two groups of dogs were infected intravenously (i.v.) or...
12.
Quihui L, Valencia M, Crompton D, Phillips S, Hagan P, Morales G, et al.
BMC Public Health
. 2006 Sep;
6:225.
PMID: 16956417
Background: Intestinal parasitic infections are a public health problem in developing countries such as Mexico. As a result, two governmental programmes have been implemented: a) "National Deworming Campaign" and b)...
13.
Daneshvar H, Hagan P, Stephen Phillips R
Parasite Immunol
. 2004 Apr;
25(11-12):589-96.
PMID: 15053780
An attenuated line of Leishmania mexicana (the L. mexicana H-line) has been established by culturing in vitro under gentamicin pressure. BALB/c mice infected with the L. mexicana H-line developed a...
14.
Hagan P, Appleton C, Coles G, Kusel J, Tchuem-Tchuente L
Trends Parasitol
. 2004 Jan;
20(2):92-7.
PMID: 14747023
Despite the limited reports of praziquantel resistance, the relative success of chemotherapy-based control programmes for schistosomiasis has prompted overdue efforts to expand the use of cheap, generic, praziquantel in sub-Saharan...
15.
Hagan P, Sharaf O
Expert Opin Biol Ther
. 2003 Dec;
3(8):1271-8.
PMID: 14640953
While there are many challenges in vaccine development, none is greater than that of developing vaccines against large metazoan parasites such as schistosomes, the parasitic worms that are responsible for...
16.
Mutapi F, Hagan P, Woolhouse M, Mduluza T, Ndhlovu P
Parasite Immunol
. 2003 Jun;
25(2):87-97.
PMID: 12791104
Humoral responses directed against Schistosoma mansoni soluble egg antigen were studied in Zimbabwean children before and after treatment with either praziquantel (PZQ) or oxamniquine (OXAM). Treated children showed a significant...
17.
Daneshvar H, Coombs G, Hagan P, Stephen Phillips R
J Infect Dis
. 2003 May;
187(10):1662-8.
PMID: 12721947
A method for attenuation of Leishmania species by culturing in vitro under gentamicin pressure has been used successfully with Leishmania mexicana, L. major, L. infantum, and L. donovani. The attenuated...
18.
Carneiro-Santos P, Alves-Oliveira L, Correa-Oliveira R, Hagan P
Parasite Immunol
. 2003 Mar;
24(9-10):493-7.
PMID: 12654092
Schistosomiasis mansoni remains a significant public health problem in many parts of the tropics and subtropics. Clinical manifestations range from the asymptomatic intestinal form through to the hepatosplenic form of...
19.
Druilhe P, Hagan P, Rook G
Trends Microbiol
. 2002 Oct;
10(10 Suppl):S38-46.
PMID: 12377567
Models currently occupy the crucial first step in the research flow for the development of new drugs and vaccines. Some animal models are better at reflecting the host-pathogen interaction in...
20.
Hagan P, Projan S, Rosamond J
Trends Microbiol
. 2002 Oct;
10(10 Suppl):S1-2.
PMID: 12377560
No abstract available.